Skip to main content
Episurf logo

Episurf — Investor Relations & Filings

Ticker · EPIS ISIN · SE0003491562 LEI · 549300GORBCSMHZB2J75 ST Manufacturing
Open in API
Filings indexed 873 across all filing types
Latest filing 2019-04-05 Capital/Financing Update
Country SE Sweden
Listing ST EPIS

About Episurf

https://episurf.com/

Episurf is a medical device company that develops and commercializes patient-specific solutions for treating painful joint injuries. The company's core technology utilizes 3D imaging to create personalized orthopedic implants and surgical instruments tailored to each patient's unique anatomy and cartilage defect. Its primary product line, the Episealer® system, provides minimally invasive implants for treating cartilage and underlying bone lesions in the knee and ankle joints. The objective of this individualized approach is to repair the joint, alleviate pain, and restore function, offering a treatment option for patients, often middle-aged, who are not yet candidates for total joint replacement surgery.

Recent filings

Filing Released Lang Actions
Episurf Medical genomför kapitalanskaffning om 98 MSEK, Styrelsen föreslår förändring av bolagsordningen, tidigarelägger kvartalsrapport och säger upp finansieringsavtal
Capital/Financing Update Classification · 1% confidence The document is a press release announcing a significant corporate action: a rights issue ('kapitalanskaffning om 98 MSEK genom en delvis säkerställd företrädesemission'). It also mentions related corporate governance changes (proposing changes to the articles of association) and the early publication of a quarterly report. The core subject is fundraising and capital structure change. This aligns directly with the definition for 'Capital/Financing Update' (CAP). Although it mentions the upcoming quarterly report, the primary focus and driver of the announcement is the capital raise, making CAP the most appropriate classification over ER or RPA.
2019-04-05 Swedish
Nytt patentbeviljande i Japan för Episurf Medical
Regulatory Filings Classification · 1% confidence The document announces a new patent grant in Japan for Episurf Medical concerning a surgical instrument design ("Design method of a rig"). It includes commentary from the CRO & Head of IP and concludes with a statement that the information is required to be made public under EU Market Abuse Regulation (MAR) and was released on April 4, 2019. This type of announcement, which is a specific corporate event update (patent grant) that doesn't fit into standard financial reports (10-K, IR, ER) or specific corporate actions (DIV, CAP, M&A), is best classified as a general regulatory announcement or miscellaneous filing. Since there is no specific category for 'Patent Grant Announcement', the most appropriate fallback category is 'Regulatory Filings' (RNS). The document is short and serves as an official disclosure.
2019-04-04 Swedish
New Japanese patent approval for Episurf Medical
Regulatory Filings Classification · 1% confidence The document announces a specific corporate event: the granting of a new Japanese patent for Episurf Medical. It includes details about the patent, a quote from the CRO & Head of IP, contact information, and a boilerplate 'About' section. Crucially, the final paragraph states: "This information is information that Episurf Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication... on 4 April 2019." This structure is typical of a regulatory disclosure or press release concerning intellectual property or a material event that is not a standard financial report (like 10-K, IR, or ER). Since there is no specific category for 'Patent Grant Announcement,' and it is a material regulatory disclosure, the most appropriate fallback category is 'Regulatory Filings' (RNS), as it serves as a general regulatory announcement.
2019-04-04 English
Professor Niek van Dijk ansluter till Episurf Medicals Clinical Advisory Board
Board/Management Information Classification · 1% confidence The document announces the addition of Professor Niek van Dijk to Episurf Medical's Clinical Advisory Board. It details his qualifications, expertise in ankle surgery, and current roles. This type of announcement concerns changes in the company's advisory structure or key personnel appointments related to medical/scientific guidance, which aligns best with the 'Board/Management Information' category, as advisory boards often function similarly to management/governance bodies in strategic direction. It is not a financial report (10-K, IR, ER), a shareholder vote result (DVA), or a director's dealing (DIRS). Therefore, MANG (Board/Management Information) is the most appropriate classification.
2019-04-01 Swedish
Prof. Niek van Dijk is joining Episurf Medical’s Clinical Advisory Board
Board/Management Information Classification · 1% confidence The document announces the addition of a new member, Prof. Niek van Dijk, to the company's Clinical Advisory Board. This is a change concerning key personnel/advisors of the company. Based on the provided definitions, the category 'Board/Management Information (Code: MANG)' covers 'Announcement of changes in the company's board of directors or senior management.' While an advisory board is slightly different from the main board or senior management, this type of personnel announcement fits best under MANG compared to other specific categories like financial reports, legal updates, or shareholder actions. The document is a direct announcement, not a report itself, and its content is focused entirely on this personnel change.
2019-04-01 English
Pre-clinical study proving chondrointegration accepted for publication in scientific journal
Regulatory Filings Classification · 1% confidence The document is a short announcement from Episurf Medical stating that a peer-reviewed article detailing pre-clinical study results regarding their Episealer® implant has been accepted for publication in a scientific journal. It quotes the CEO and provides contact information. It is not a full financial report (like 10-K or IR), an earnings release (ER), or a management discussion (MDA). It is an announcement about scientific/medical progress, which does not fit neatly into the primary financial categories. Given the options, the most appropriate fallback category for a significant, non-financial regulatory/scientific update that doesn't fit elsewhere is 'Regulatory Filings' (RNS), as it is a mandatory disclosure under market abuse regulations regarding company developments.
2019-03-11 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.